FDA Approves First New Sunscreen Ingredient In More Than Two Decades

The U.S. Food and Drug Administration has approved bemotrizinol as a sunscreen active ingredient, marking the first addition to the agency’s list of permitted sunscreen filters in more than two decades.

The decision follows a review of extensive safety and efficacy data gathered from international markets, particularly Europe, where bemotrizinol has been widely used for years.

The ingredient provides broad-spectrum protection against both UVA and UVB radiation and is known for its ability to remain stable when exposed to sunlight.

The ingredient will initially be marketed by DSM-Firmenich under the brand name Parsol Shield.

The company will retain exclusive rights to the filter for 18 months before it becomes available to other manufacturers.

Supporters argue the move will give consumers access to more advanced sun protection technologies already available in many other countries.

Related Tweet:

The first new sunscreen active ingredient in 20 years! As the temperatures heat up this summer, FDA is happy to announce expanded options for consumers. Learn more: https://t.co/01tLN5fyiU pic.twitter.com/EOTdvyZNrc

— U.S. FDA (@US_FDA) June 9, 2026

Also Read:

FDA To Review Moderna’s Flu Vaccine After Initial Rejection

The U.S. Food and Drug Administration has reversed course and will review Moderna’s new mRNA-based flu vaccine after initially rejecting the application, the company said Wednesday. Earlier this month, the FDA declined to accept Moderna’s filing, citing concerns that the clinical trial did not include an adequate

tippinsightsTIPP Staff

FDA Chief Shares Attainable Holiday Health Advice

By Elizabeth Troutman Mitchell, The Daily Signal | December 24, 2025 You don’t have to be up to the 100 pushup, 50 pullup “Bobby Kennedy Fitness Challenge” this Christmas to follow U.S. Food and Drug Administration Commissioner Dr. Marty Makary’s holiday health recommendation. When asked by The Daily

tippinsightsTIPP Staff